Rhomboid Intercostal Block with Subserratus Plane Block in Bariatric Surgery (NCT06729515) | Clinical Trial Compass
CompletedNot Applicable
Rhomboid Intercostal Block with Subserratus Plane Block in Bariatric Surgery
China114 participantsStarted 2023-01-01
Plain-language summary
Standard analgesic techniques such as patient-controlled analgesia (PCA) and continuous epidural analgesia (CEA) are effective but associated with considerable side effects, including nausea, hypotension, and respiratory depression. This study aimed to evaluate the efficacy and safety of the rhomboid intercostal block combined with subserratus plane block (RISS) compared to PCA and CEA for postoperative analgesia in bariatric surgery.
Who can participate
Age range20 Years – 41 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* aged 20-41 years
* ASA I-III
* body mass index (BMI) ≥27.5 kg/m² or BMI \<27.5 kg/m² with obesity-related comorbidities (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, or non-alcoholic fatty liver disease)
* failure to achieve significant weight loss with conservative management (diet and/or pharmacotherapy)
* the capacity for postoperative care and lifestyle modification
Exclusion Criteria:
* severe cardiopulmonary or hepatic disease
* untreated major psychiatric disorders or active substance abuse potentially affecting postoperative lifestyle management; pregnancy or intention to conceive
* inability to complete long-term follow-up or lifestyle adjustments; or inability to obtain complete trial data
* Patients who refused to provide written informed consent were excluded